Literature DB >> 8099419

Prolonged QT interval with halofantrine.

A Castot, P Rapoport, P Le Coz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8099419

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine.

Authors:  I D Lightbown; J P Lambert; G Edwards; S J Coker
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation.

Authors:  D R Abernethy; D L Wesche; J T Barbey; C Ohrt; S Mohanty; J C Pezzullo; B G Schuster
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

3.  Inhibition of HERG potassium channels by the antimalarial agent halofantrine.

Authors:  H Tie; B D Walker; C B Singleton; S M Valenzuela; J A Bursill; K R Wyse; S N Breit; T J Campbell
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.

Authors:  Andrew J Batey; Susan J Coker
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.

Authors:  José A Sánchez-Chapula; Ricardo A Navarro-Polanco; Michael C Sanguinetti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-19       Impact factor: 3.000

Review 6.  Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 7.  Clinical pharmacokinetics of halofantrine.

Authors:  J Karbwang; K Na Bangchang
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.

Authors:  G Edwards; P A Winstanley; S A Ward
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

9.  Evaluation of the efficacy and safety of artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in Nigerian infants and children.

Authors:  Catherine O Falade; Oluwatoyin O Ogunkunle; Hannah O Dada-Adegbola; Adegoke G Falade; Patricia Ibarra de Palacios; Philip Hunt; Mailis Virtanen; Ayoade M Oduola; Lateef A Salako
Journal:  Malar J       Date:  2008-11-27       Impact factor: 2.979

Review 10.  Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base.

Authors:  Olivier Bouchaud; Patrick Imbert; Jean Etienne Touze; Alex N O Dodoo; Martin Danis; Fabrice Legros
Journal:  Malar J       Date:  2009-12-10       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.